Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Operating Expenses (2016 - 2025)

Immuron (IMRN) posted Operating Expenses of -$5.2 million for Q2 2025, down 7720.61% on a QoQ basis from -$66175.0 in Q3 2024, and up 20.93% year-over-year from -$4.3 million in Q2 2024.

Analysis

Immuron (IMRN) Operating Expenses (2016 - 2025) Analysis & Trends

Immuron has reported Operating Expenses for 10 years, with the latest figure at -$5.2 million in Q2 2025.

  • On a quarterly basis, Operating Expenses rose 20.93% year-over-year to -$5.2 million in Q2 2025; TTM through Jun 2025 was -$16.2 million, a 38.81% decrease from a year earlier, with the FY2026 full-year figure at -$6.2 million, down 7620.65% from the prior year.
  • Operating Expenses was -$5.2 million for Q2 2025 at Immuron, down from -$66175.0 in the prior quarter.
  • The five-year high for Operating Expenses was $249911.6 in Q4 2021, with the low at -$6.5 million in Q2 2024.
  • Average Operating Expenses over 5 years is -$2.6 million, with a median of -$2.3 million recorded in 2021.
  • The sharpest annual moves came in 2023 and 2025: Operating Expenses plunged 1688.7% in 2023, then gained 20.93% in 2025.
  • Over 5 years, Operating Expenses stood at $249911.6 in 2021, then tumbled by 199.22% to -$247958.7 in 2022, then slumped by 1688.7% to -$4.4 million in 2023, then jumped by 98.51% to -$66175.0 in 2024, then sank by 7720.61% to -$5.2 million in 2025.
  • The last three Operating Expenses figures came in at -$5.2 million (Q2 2025), -$66175.0 (Q3 2024), and -$6.5 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -1.05 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 367.83 Mn
10 Immuron 10.28 Mn 1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -5.18 Mn
Sep 9, 2024 -66,174.98
Jun 30, 2024 -6.54 Mn
Dec 31, 2023 -4.44 Mn
Jun 30, 2023 -458,450.49
Dec 31, 2022 -247,958.71
Dec 31, 2021 249,911.60
Jun 30, 2021 -4.12 Mn
Dec 31, 2020 343,408.53
Jun 30, 2020 -3.20 Mn
Dec 31, 2019 509,279.32
Dec 31, 2018 3.05 Mn
Dec 31, 2017 -3.23 Mn
Dec 31, 2016 -2.19 Mn
Jun 30, 2016 -3.69 Mn